Zero Point Five Therapeutics
Signal active
Organization
Contact Information
Overview
Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis. A pharmaceutical company is developing a single-dose formulation for soil-transmitted helminthiasis (STH). STH is a disease that primarily affects poor rural communities of color with inadequate sewage systems.
About
Industries
Health Care, Pharmaceutical, Therapeutics
Founded
2018
Employees
0
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Zero Point Five Therapeutics headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Health Care and has secured $173.3M in funding across 24 round(s). Their latest funding round, Series A - Zero Point Five Therapeutics, raised $7.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$7.2M
Details
2
Zero Point Five Therapeutics has raised a total of $7.2M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | |||
| 2023 | Early Stage Venture | 7.2M |
Investors
Zero Point Five Therapeutics is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Zero Point Five Therapeutics | - | FUNDING ROUND - Zero Point Five Therapeutics | undefined |
| Portfolia | - | FUNDING ROUND - Portfolia | undefined |
| Zero Point Five Therapeutics | - | FUNDING ROUND - Zero Point Five Therapeutics | 7.2M |
| Portfolia | - | FUNDING ROUND - Portfolia | 7.2M |
Recent Activity
There is no recent news or activity for this profile.